MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
sale of common stock
$477,642
Proceeds from warrant
exercise, net of expenses
$47,040
Net cash provided by
financing activities
$524,682
Net increase in cash
and cash...
-$1,308,691
Canceled cashflow
$524,682
Equity-based compensation
$147,334
Accrued expenses
$94,613
Change in value of
equity method...
-$76,920
Amortization of intangible
assets
$141
Net cash used in
operating activities
-$1,833,373
Canceled cashflow
$319,008
Loss from operations
-$1,793,651
Prepaid expenses and
other current assets
$243,896
Accounts payable
-$114,834
Back
Back
Cash Flow
source: myfinsight.com
ADIAL PHARMACEUTICALS, INC. (ADIL)
ADIAL PHARMACEUTICALS, INC. (ADIL)